Tackling a hard-to-treat childhood cancer by targeting epigenetic changes

A very difficult-to-treat child leukemia may benefit from the discovery of a small but potent epigenetic change that launches the cancer – but could potentially be reversed relatively easily, preventing cancer-promoting genes from being turned on. The study, led by researchers at Children's Hospital Boston and the Dana-Farber Cancer Institute, is the cover article in the November 4 issue of Cancer Cell.

If you want to include this story in your blog, copy and paste this formatted text:

<p><a href="http://www.physorg.com/news144947385.html">Tackling a hard-to-treat childhood cancer by targeting epigenetic changes</a></p> <p>A very difficult-to-treat child leukemia may benefit from the discovery of a small but potent epigenetic change that launches the cancer – but could potentially be reversed relatively easily, preventing cancer-promoting genes from being turned on. The study, led by researchers at Children's Hospital Boston and the Dana-Farber Cancer Institute, is the cover article in the November 4 issue of <I>Cancer Cell</I>.</p>